Adimab initiates independent collaborations with Biogen Novo and Idec Nordisk Adimab, LLC, a technology head in the discovery of fully human antibodies, announced the initiation of two independent collaborations with Biogen Idec and Novo Nordisk today. Over the past 2 yrs, Adimab has generated collaborations with multiple leading pharmaceutical businesses, including: Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Human Genome Sciences, and Biogen Idec and Novo Nordisk now.Yet another circular of immunisation was carried out earlier this full week, targeting 6.4 million Indonesian children beneath the age of five in West Java, Banten and Jakarta provinces. The WHO says that Lampung and Central Java will be included in the next stage of the large-level immunisation campaigns which will start in August. According to the United Nations health agency, Angola is the 17th, polio-free nation to be reinfected since 2003 previously, when the virus began circulating in Africa broadly. A 10-month ban on vaccination in the northern state of Kano was blamed for the virus spreading across Africa, reaching Saudi Yemen and Arabia, but genetic analysis shows it was imported from another endemic region, India, rather than Nigeria.